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Abstract 
 
This paper examined the psycho physiological effects of coffee consumption on anxiety as reported by University students. The 
relationship between coffee consumption and anxiety was also explored. It was hypothesized that heavy caffeine users would 
report significantly higher anxiety and more psychophysical symptoms of caffenism more than non-users.  A sample size of 
447-university students made up of 239 males and 208 females within ages 16-36 years (M = 22.7; SD = 2.92) participated in 
the study. All respondents completed an adapted version of STAI forms Y-1 and Y-2 which measures state-trait anxiety. 
Analysis of data revealed significant difference between coffee users and non-users on state anxiety. The quantity and 
frequency of daily coffee consumption were found to be related to the symptoms exhibited on state anxiety. There was no 
significant sex difference on the frequency and quantity of coffee consumption but a significant age difference in favour of 
younger respondents was recorded on frequency of coffee consumption. Various symptoms reported by the respondents 
confirmed the stimulating properties of caffeine.  
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1. Introduction 
 
In the last four decades, several attempts have been made to examine the psychotropic effects of caffeine on human 
being. Previous attention has been directed towards its effects on motor responses, visual monitoring (Baker et al, 1972) 
Nash, 1962) Wakefulness; (Goldstein, et al 1965) tolerance; (Colton et al, 1967). Regina, et al (1974; human 
performance, motor coordination, judgment and mood;( Weiss and Latries (1962).  
Human cardiac response has been subjectively reported to be affected by caffeine ingestion. Particularly in this 
direction is its ability to raise arterial blood pressure, pulse rate, and cardiac irregularities evident in bradycardia and 
tachycardia. The vasodilatory property of this alkaloid had led to studies focusing on effects of caffeine on alertness and 
cardiac arrhythmia. Insomnia, nervousness, and headache have been reported among coffee users (Harne, 1970). Within 
the gastrointestinal system, caffeine has the potential to produce nausea, vomiting, diarrhea, epigastric pain, and 
occasionally, peptic ulcer and hematemesis (Truitt, 1971; Greden, 1974). A significant effort has also been directed on 
the effect of coffee on Blood pressure; (Freestone and Ramsay, 1982; Periti, et al, 1987; Lane, et al, 1998 Al’ absi et al, 
1998).  
Grollman (1951) pointed out that although ideas become clearer, thought flows more freely and fatigue and 
drowsiness disappear, caffeine ingestion often leads to inhibition of logical, connected thought, and much effort is 
required to focus attention on a single object. Grollman (1930) study revealed marked nervousness, slight tremor, and a 
feeling of anxiety. Small doses of caffeine were without effect on the cardio-vascular system. Larger doses (0.5 to 1.0 
gram) caused in most cases, a rise in the oxygen consumption (10 to 35 percent,) slight or no changes in the pulse rate, 
an increase in the arteriole-venous oxygen difference, and a slight rise in the cardiac output. Gins burg and Weintrailb 
(1976) have also examined the soporific effect of coffee in patients with senile dementia. 
In most parts of the world, coffee is consumed more frequently than any other beverage. Several authors 
(Winstead, 1976; Nehhg, et al, 1992; Rall, 1980 and AL’ Abs, 1998), have corroborated the ability of caffeine to activate 
the central Nervous system and increase the circulating catecholamines and free fatty acids. It has been claimed (Ritchie, 
1970; Truitt, 1971, Goldstein, 1965) that coffee intake promote rapid, clear thinking, improved intellectual effort, enhanced 
mental acuity and decreased drowsiness, fatigue, and inaction time. Tyler (1975) characterized caffeine as a cortical 
stimulant, which relieves fatigue, increases awareness, decreases appetite, and often becomes moderately addictive. 
Caffeine has been described as an almost ideal stimulant in that it enhances cognition and motor activity and produces 
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few or no side effects for most people (Thompson, 1975). There is the widespread belief that caffeine enhances mental 
and psychical performance but experimental support for this belief is neither extensive nor equivocal 
In general population, Baker and Theologus (1972) reported that caffeine is taken in many forms to increase 
“alertness”. The premise that caffeine aids alertness seems to have broad acceptance in spite of a relative absence of 
empirically convincing evidence. This has led to its general consideration as a socially acceptable and relatively benign 
psychotropic drug despite its ability to produce dependence, tolerance and withdraw symptoms on heavy use (Ritchie, 
1970). However, the general public has been reluctant to classify caffeine as a drug. This substance has been 
domesticated to the extent of its incorporation into our daily life in such rituals as the coffee break and the coffee club 
(Brecher, 1972).  
The clinical literature on psychological and physiological reactions to caffeine and caffeine containing beverages is 
extensive. As noted earlier, caffeine is not without its side effects. Behavioural effects are partially dependent upon the 
tolerance level of user, which is increased by chronic usage. Doses that increase tolerance result in indigestion; 
nervousness and insomnia (Leukel, 1972; Childs, 1978). Of research interest is “Caffeinism” in which high caffeine 
consumption produced a pattern of physiological and psychological reactions indistinguishable from anxiety neurosis. 
Greden (1978) has defined caffeinism pharmacologically as the ingestion and consequent actions of high doses of 
caffeinism, whether from coffee, tea, cola drinks, over-the-counter substances, or prescription medications. Symptoms of 
caffeinism include nervousness, irritability, agitation headache, tachypnea, tremulousness, reflex hyper excitability, and 
occasional muscle twitching (Ritchie, 1970; Hire, 1978). 
The anxiety constellation of caffeinism has long been recognized; the media have aptly described it as coffee 
nerves. In addition to toxic manifestations of caffeine stimulation, similar clinical complaints can result from a 
characteristic caffeine withdrawal syndrome. Goldstein and Kaiser (1969) found in a survey among housewives that 
heavy coffee users described a typical set of dysphoric symptoms if they omitted morning coffee. Symptoms include 
irritability, inability to work effectively, nervousness, lethargy, and restlessness.  
Further research has confirmed a significant relationship between excessive caffeine consumption and high level 
of self-reported anxiety and depression in hospitalized patients (Winstead, 1976, Greden et al, 1978,). Among College 
undergraduates, Gilliland and Andress (1981) established a strong relationship between high caffeine consumption and 
anxiety. The results obtained corroborate some previous findings in this regard (Ritchie, 1970; Hive, 1978; Goldstein et al 
1969; Colton, et al 1967; Greden et al 1978; Winstead, 1978; Stillner, et al 1978). 
The present investigation was designed to examine the relationship between caffeine consumption, an evidence of 
psycho physiological symptoms of caffeinism and anxiety among University undergraduates. It is hypothesized that heavy 
caffeine users would report significantly higher anxiety and more psychophysical disorders and symptoms of caffeinism 
more than non-users. 
 
2. Method 
  
For the examination of individual differences in anxiety and caffeine consumption 447 university students comprising of 
239 males and 208 females within the age of 16 years and 36 years (m. 22.7, S.D. 2.92) participated in this study. The 
students were asked to fill a set of questionnaire, which is made up of three sections. The first part deals with a number of 
items dealing with coffee consumptions and associated feelings and symptoms observed on ingestion, while the second 
section measured the anxiety level of the respondents. The Spielberger (1983) version of the State-Trait Anxiety 
Inventory (STAI) form Y-1, and Y-2 were used to achieve this. Both STAI forms (Y-1 and Y-2) were modified version of 
the STAI series, developed to measure state and trait anxiety which is momentary of transitory or situation specific 
emotion, characterised by feelings of tension, apprehension, and automatic arousal. Each of the forms has 20 items 
designed to measure different aspects of anxiety as a characteristics of personality. The STAI has been adapted for the 
use of professionals in Nigeria after several years of research at restandardising it in order to enhance its suitability and 
relevance for Nigerians. For Nigerian samples, it has a reliability coefficient of 0.61 for test -retest at two weeks interval 
and high concurrent validity of 0.69 with Zuckerman and Lubin (1965) MAACL (anxiety) Scale. The last part of the 
questionnaire assessed the occurrence of side effects in areas of mood, tension, sleep disturbance, intellectual 
functioning, and general somatic (muscular/sensory) cardiovascular, respiratory and autonomic systems. A “symptom 
experience” score was obtained by summing a subject’s responses indicating an increase in a symptom. Subjects 
responded by checking the appropriate response on two different response formats; yes/no and 3 – point scale ranging 
from “Never” to “always”. . Of the total 424 data found analysable, 248 were coffee users while the remaining 176 
subjects were non-coffee users. These two categories were so designated as users and non-users in most of the 
analyses.  
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3. Procedure 
  
The respondents were questioned regarding the number of cups of coffee they drank per day, and they were classified 
into four groups; no coffee, 1-2 cups, 3-4 cups and 5 or more cups. A non-coffee user was one who, by his own 
estimation, usually drank no more than one cup of coffee or tea or bottle of cola beverage per day; all others are 
described as “coffee users”. The frequency of coffee consumption was also ascertained. Coffee users indicated the 
frequency of their coffee consumption in this order, daily, 2-3 times weekly and occasionally. The mean, standard 
deviation and median scores of these categories of users on quantity and frequency of coffee consumption on state-trait 
anxiety were presented in Table 1. We hypothesised that coffee users would report significant higher anxiety level and 
more psychological symptoms of caffeine than non-coffee users. 
 
Table 1: Variability of Respondents on State-Traits Anxiety Inventory Scales 
 
Da
ily
 C
off
ee
 
Co
ns
um
pti
on
 Levels 
Trait-Items State-Items 
N Mean Std Median N Mean Std Median 
None 93 44.53 9.09 44 98 45.02 8.27 46 
1-2 Cups 177 45.57 7.61 45 180 48.83 9.16 48 
3-4 Cup 11 48.18 5.12 46 11 50.55 5.32 50 
5 or more Cups 4 50.00 8.52 50 5 51.4 9.34 49 
Total 285 45.39 8.08 45 294 47.67 8.93 47 
Fr
eq
ue
nc
y o
f 
Co
ffe
e 
Co
ns
um
pti
on
 Daily 43 46.00 7.23 47 44 48.73 9.45 48.5 
2-3 times per week 41 46.17 6.62 47 43 48.14 7.23 48 
Weekly 20 50.00 7.9 48 21 52.14 12.60 48 
Occasionally 107 44.23 8.46 44 110 47.37 8.58 47 
Total 211 45.52 7.97 46 218 48.26 9.01 48 
 
4. Results  
  
Descriptive analysis on reasons for consuming coffee varied. Sixty five percent of coffee users indicated likeness for the 
taste of while about fifty-three percent finds it enjoyable to drink. Only twenty – four percent felt the need for it, while only 
eighteen per cent had cultivated the habit of coffee consumption. Seventeen per cent of coffee users recognised the 
relaxation ability of coffee while an insignificant three percent noticed the depressed activity of coffee as they confessed 
that it slows one down. The influence of friends was also found to be insignificant. Only seven percent of all coffee users 
indicated that their friends lured them into coffee consumption. 
On the stimulating properties of coffee consumption, of all the users, fifty two percent of acknowledged the 
stimulating ability of coffee together with forty-eight percent indicating coffee power to wake one up. Twenty-eight percent 
testified to coffee’s energy yielding ability, about 21 per cent noticed the feeling of well being and another thirty percent 
admitted that coffee gets one going in the morning. There were some noticeable behaviour changes noticed among 
coffee users after drinking morning coffee and were reported here in the order with which they were found most 
prominent among the subjects. They include “becoming more alert (79.4%), become more active (77.5%), work more 
efficiently (73.8%), become more relaxed (42.2%), “perking” (38.6%), less irritable (25.9%). The least noticeable 
symptoms include nervousness, less efficient (10.1%), drowsiness (8.0%) and sluggishness (4.8%). Similarly, coffee 
users noticed that whenever they drank coffee, they tend to have these stimulatory properties of caffeine arranged in 
descending order; decreased drowsiness (61.6%), rapid clear thinking (53.3%), less fatigue (52.4%), disturbed sleep 
(52%), enhanced mental acuity (51.9%) and improved intellectual ability (46.6%).  
Symptoms characteristics of negative effects of coffee consumption were less noticeably among coffee users, the 
most reported were: fast breathing (15.2%), palpitation (14.5%), loss of appetite (26.8%), stomach irritation (11.0%) and 
diarrhea (5.9%). Of these 248 coffee users, forty-one percent experienced nervousness occasionally, fifty-two percent 
reported occasional restlessness, and about forty-one percent noticed headache occasionally. Among these users, 
twenty seven percent occasionally felt agitated, while about 19% experienced tremor of lower limbs. Another 30% 
reported occasional muscle twitching. All these symptoms revealed elements of caffeine withdrawal among coffee users. 
If they however missed their daily coffee consumption, coffee users reported these symptoms; inability to work effectively 
(86.5%), not active (78.4%), not become alert (79.2%) and not be energetic (77.7%), not fully awake (85.5%). Only few 
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coffee users noticed headache (7.8%), irritability (8.9%), nervousness (5.5%), restlessness (14.7%), and would become 
lethargic (4.9%) if they miss daily coffee consumptions. When cross tabulated against the frequency of consumption the 
following symptoms were observed to be significant improved intellectual ability; enhanced mental acuity, rapid clear 
thinking, less fatigue, becoming more active, working efficiently, alertness, sleeping patterns, restlessness, nervousness, 
becoming irritable, headache and fast breathing. Feelings of agitation, tremor, occasional muscle twitching were however 
found not to be influenced by the frequency of coffee consumption. (See table 2) 
 
Table 2: Frequency of Coffee Consumption on Self Reported Symptoms 
 
Item Π2-value df P-value 
Improved intellectual ability 39.17 3 0.0001* 
Enhanced mental acuity 29.86 3 0.0001* 
Rapid clear thinking 47.91 6 0.0001* 
Less fatigue 22.18 3 0.0001* 
Becoming more active 24.91 6 0.002*
Working efficiently 29.56 3 0.0001* 
Alertness 20.36 6 0.002*
Sleeping patterns 42.42 6 0.0001* 
Restlessness 29.31 6 0.001*
Nervousness 14.54 6 0.02*
Becoming irritable 27.90 6 0.0001* 
Feelings of agitation 8.62 6 0.19
Headache 14.20 6 0.03*
Hand shaking (tremor) 10.08 6 0.12
Occasional Muscle Twitching 10.41 6 0.11
Breathing becoming faster 17.84 3 0.0001* 
* Statistically significant at P  0.05 
  
Table 3 and 4 presents the result on the difference between users and non-coffee users on state and trait anxiety. It was 
shown that coffee users had significant state anxiety more than non-users [t (341) = 3.40; P < 0.001]. Scores of users 
were found to be higher on state anxiety more than non-coffee users (m = 45.63, S.D = 8.09) with a mean difference of 
(m = 48.83, S.D = 9.05) 3.20. The difference between users and non-users on trait anxiety were not statistically 
significant [t (337) = 1.32; P > 0.05], thus confirming non significant influence of coffee consumption on trait anxiety. 
 
Table 3: T-test Comparison of Coffee Users and Non-coffee Users on State-Anxiety 
 
Group N Mean Std Dev. Tval df Sig. (2-tailed) Mean Diff 
Coffee users 194 48.83 9.05
 3.40* 341 0.001 3.20 
Non-Coffee Users 149 45.63 8.09  Total 343
*Statistically significant, P < 0.001 
 
Table 4: T-test Comparison of Coffee Users and Non-Users on Trait-Anxiety 
 
Group N Mean Std Dev. Tval df Sig. (2-tailed) Mean Diff 
Coffee users 190 45.65 7.62
 1.32 337 0.187 1.13 
Non-Coffee Users 149 44.52 8.02  Total 339
* Not statistically significant. P >0.05 
 
The quantity of daily coffee consumption were also found to be related to the symptoms exhibited on state anxiety (F 
ISSN 2039-2117 (online) 
ISSN 2039-9340 (print) 
        Mediterranean Journal of Social Sciences 
            MCSER Publishing, Rome-Italy 
Vol 5 No 15 
July  2014 
          
 468 
(3,290) = 4.724; P < 0.003) Scheffe and LSD post hoc tests revealed significant difference between those who consumed 
1-2 cups of coffee daily and none coffee users. There is also a difference between those with 34 cups daily consumption 
and non-coffee users. Quantity of daily coffee consumption however did not make any significant influence on trait 
anxiety (F (3,281) = 1.259; P > 0.05). This is shown in Table 5. 
 
Table 5: One-way ANOVA of the Quantity of Daily Coffee Consumption on State- Trait Anxiety 
 
 Sum of Squares. df Mean Square F Sig. 
State 
 
 
Between Groups
Within Groups 
Total 
1089.786
22301.548 
23391.333 
3
290 
293 
363.262 
76.902 4.724 .003* 
Trait 
Between Groups
Within Groups 
Total 
245.800
18282.186 
18527.986 
3
281 
284 
81.933 
65.061 1.259 .289 
 
Table 6: One-way ANOVA of Frequency of Coffee Consumption on State- Trait Anxiety 
 
 Sum of Squares. df Mean Square F Sig. 
State 
 
 
Between Groups
Within Groups 
Total 
648.130
15147.198 
15795.328 
3
188 
191 
216.043 
80.570 2.681 .048* 
Trait 
Between Groups
Within Groups 
Total 
476.228
10422.179 
10898.406 
3
183 
186 
158.743 
56.952 2.787 .042* 
 
On the frequency of coffee consumption and anxiety state, the result in Table 6 revealed a significant influence of 
frequency of consumption on both state and trait anxiety. [State: F (3,188) = 2.681; P < 0.05]; trait: F (3,183 = 2.787; P < 
0.05). Schefe and LSD post hoc tests showed a significant difference on state anxiety for those with weekly coffee 
consumption and occasional drinkers (M.D = 4.77; P < 0.027). This difference becomes clearer on trait anxiety as those 
with daily consumption were found to differ from those who consume coffee on weekly basis. So also is the difference 
between weekly drinkers and occasional drinkers of coffee (M.D. = -5.76; P < 0.030). 
We also found a positive significant relationship between symptoms experienced by coffee user and both levels 
(state and trait) of anxiety. (State, 0.18; P < 0.042; trait r = 0.207: P < 0.020). Symptoms experienced were: influenced 
more by the frequency of coffee consumption than the quantity (number of cups) consumed daily (F (3, 134) = 6.86; P < 
0.000). Scheffe post hoc test revealed a significant mean difference of 6.72, P < 0.023 between symptoms experienced 
by daily users of coffee and occasional users. (See Table 8). Significant differences were also found in the symptoms 
experienced by occasional users and those with 2-3 times weekly. (M.D. = 9.16, P < 0.001). Although quantity consumed 
daily had no significant influence on the symptoms experienced generally, it was however discovered that when morning 
coffee was missed, symptoms experienced were both influenced by the quantity and frequency of coffee consumption 
[quantity: F [3, 239) = 3.98; P < 0.008], [frequency: F(3, 201) = 2.765; P < 0.043]. (See Table 7). 
 
Table 7: One Way Analysis of Variance on the Influence of Quantity and Frequency of Coffee consumption on Symptoms 
Experienced If Users Missed Morning Coffee 
 
 Sum of Squares Df Mean Square F Sig. 
Quantity 
Between Group 296.954 3 98.985 3.981 .009* 
Within Groups 5942.832 239 24.865  Total 6239.786 242
Frequency 
Between Groups 181.752 3 60.584 2.765 .043* 
Within Groups 4404.472 201 21.913  Total 4586.224 204
* Statistically significant; P < 0.05 
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Table 8: One Way Analysis of Variance on the Influence of Quantity and Frequency of Coffee Consumption on 
Symptoms Experienced by Coffee Users 
 
 Sum of squares Df Mean square F Sig. 
Quantity 
Between Group 1950.039 3 650.013 6.856 .000 
Within Groups 12705.061 134 94.814  Total 14655.100 137  
Frequency 
Between Groups 248.923 3 82.974 .760 .519 
Within Groups 14748.308 135 109.247  Total 14997.232 138
* Statistically significant at P < 0.05 level of significance. 
 
In addition, there were notable differences in responses to trait items of the STAI (which asses how one generally feels). 
High and moderate consumers obtained significantly higher mean and median scores, indicating significantly greater 
levels of trait anxiety (See table 1). When we evaluated state scale items from the STAI (which measure how one feels at 
the moment), we observed similar patterns; total mean and median scores on the state scale were again significantly 
higher for the highest consumers (See table 1). 
It was also discovered that quantity (no. of cups) of coffee consumed daily had effect on being nervous, tremor 
experience restless and feelings of agitation but not related to other symptoms. The higher the number of cups of coffee 
consumed, the more noticeable were these symptoms. Table 9 has the results on Quantity of daily consumption and 
reported symptoms. 
 
Table 9: Relationship Between Quantity (No of cups) of Daily coffee Consumption and Self Reported Symptoms 
 
Item Π2-value df P-value 
Improved intellectual ability 4.61 9 0.87 
Enhanced mental acuity 0.24 3 0.97 
Rapid clear thinking 3.94 3 0.69 
Fatigue 0.54 3 0.911 
Sleeping patterns 2.80 3 0.42 
Restlessness 16.78 6 0.01* 
Nervousness 21.59 6 0.001* 
Dronosness 5.69 3 0.13 
Palpitations 2.59 3 0.46 
Breathing becoming faster 0.39 3 0.94 
Feeling of Agitation 13.38 6 0.04* 
Hand shaking (tremor) 5.54 6 0.04* 
Occasional muscle twitching 3.33 6 0.77 
Headache 7.10 6 0.31 
* Statistically significant at P  0.05 
 
Examination of sex difference showed a higher number of coffee consumers to be males (147), compared with the 
females (100), and there is no significant difference in their frequency of coffee consumption (x2 = 1.3777; df = 3, P > 
0.711). On age comparison on coffee consumption, respondents in the age bracket (16 – 20 years) consumed coffee 
more frequently (Daily and 2 – 3 times weekly) than 21-36 year old group (x2 = 9.420; df = 3; P < 0.024). There was 
however no significant difference between age group (16 – 20 years) and (21 – 26 year) on quantity (number of cup of 
coffee) consumed daily (x2 = 6.337; df = 3; P > -0.96). 
 
5. Discussion 
  
The present study contributes substantially to the database on the search for the relationship between intake of coffee 
and exhibition of anxiety symptoms. The main finding that emerges from this study is that coffee users differ from non-
coffee users in a number of significant ways. They tend to be somewhat older, possibly because their habit has taken 
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some years to develop. The recorded age difference were however only significant for frequency of coffee consumptions 
and not quantity consumed daily. This result on age difference is however inconsistent with Gilland and Andress (1981) 
study in which age yielded no significant effect for quantity of coffee consumption. There was no significant sex difference 
neither in the quantity nor frequency of coffee consumption. The only notable sex difference was in the number of coffee 
users, in which makes outnumbered the females. 
The most striking observable trends were the symptoms experienced in relation to the frequency of coffee 
consumption. Almost all the symptoms identified namely: improved intellectual ability, enhanced mental acuity, rapid clear 
thinking, less fatigue, becoming more active, working efficiently, alertness, sleeping patterns, restlessness, nervousness, 
becoming irritable, headache and fast breathing were significant related to and varied the frequency of coffee 
consumption. The purely caffeine withdrawal symptoms; restlessness, Nervousness and feelings of agitation were 
however significant for quantity of daily coffee consumption. Reasons taking coffee are generally the same as given by 
light users: That coffee is an enjoyable, pleasant tasting beverage that helps one wake up and get going. 
In addition, a greater proportion of them acknowledged “likeness for the taste” and the importance of a feeling of 
well being and a certain “lift” produced by morning coffee. The behavioural changes attributed to coffee consumption are 
the same in all coffee – users; make one alert, more active, perk up, and are more common depending on the frequency 
of coffee consumption. These symptoms are consistent and in line with previous studies in this direction (Goldstein and 
Kaizer, 1969; Colton, et. al., 1968). On the other hand, moderate and heavy users present a constellation of dysphoric 
symptoms (restlessness, nervousness, irritability, headache, feelings of agitation), which are features of caffeine 
withdrawal syndrome. The evidence showing that there are psycho stimulant effects of caffeine as reported by subjects in 
this study corroborates other previous findings (Ritchie, 1970, Truitt, 1971, Goldstein, 1965; Hire, 1978, Lynn, 1973). 
The results gives credence to the importance of the factors mentioned in Thompson (1975) and Theologus (1972) 
studies that caffeine enhances mental and psychical performance and also promotes alertness. There was a significant 
difference between coffee users and non-users on state anxiety. High coffee users, therefore in addition to reporting more 
psycho physiological symptoms, reported more features of state anxiety. This is similar to Greeden, et. al. (1978) 
findings. The finding on elevated anxiety symptoms among coffee users was somewhat expected because of caffeine’s 
known pharmacological actions. Not only is caffeine itself a central nervous system stimulant, it also secondarily 
increases catecholamine output, which certainly contributes to the anxiety profile (Bellet, et. al., 1969; Lev., 1967). This 
finding also corroborates Winstead (1976) study among psychiatric in patients in which anxiety inventory revealed a 
statistically significant elevation in state anxiety for the high-users group. 
The results of this study are comparable to the questionnaire data reported by Goldstein and Kaizer (1969). In a 
survey of 239 house wives, they found heavy users reporting more symptoms of caffeine withdrawal, such as 
nervousness, irritability and restlessness, a group of symptoms which in the present study found more related to quantity 
of daily coffee consumption. Quantity of coffee consumed daily had effect on nervousness, restless and feelings of 
agitation. The higher the number of cups of coffee consumed, the more noticeable were these symptoms. The results 
reported here gain support and extend the findings of Leukel (1978), Ritche, 1970, Hire, 1978 and Greden (1978) which 
revealed symptoms of Caffeinism. The relationship between exhibition of these symptoms and quantity of coffee 
consumption are not mere coincidence, the symptoms are behavioural effects caffeine consumption, which are partially 
dependent upon the tolerance level of user, which is increased by chronic usage. 
 
6. Conclusion 
  
The findings from the study have demonstrated and corroborated various previous works on the psychophysiological 
symptoms of Caffeimsm and anxiety commonly associated with coffee consumption. It is evident from self-reported 
symptoms that coffee consumption stimulates human cardiac response and capable of producing certain 
psychopathological disorders linked with state anxiety. It is thus concluded that quantity and frequency of coffee 
consumption had significant effect on the state anxiety level. 
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